Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
8 hedge funds and large institutions have $53K invested in Aoxing Pharmaceutical Company Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
14% more funds holding
Funds holding: 7 → 8 (+1)
31% less capital invested
Capital invested by funds: $77K → $53K (-$24K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$37.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$4.85K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$1.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$36K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.04K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$2K |
| 4 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$142 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $22K | +$37.8K | +138,411 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $10K | +$16.7K | +61,329 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $7K | -$4.04K | -14,822 | -25% |
|
|
4
UBS Group
Zurich,
Switzerland
| $4K | -$142 | -522 | -2% |
|
5
Barclays
London,
United Kingdom
| $4K | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| $3K | +$4.85K | +17,777 | New |
|
|
EWM
7
Evercore Wealth Management
New York
| $2K | – | – | – |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$1.06K | +3,900 | New |
|
|
9
Renaissance Technologies
New York
| – | -$36K | -114,920 | Closed |
|
|
FWM
10
Focused Wealth Management
Newburgh,
New York
| – | -$2K | -7,435 | Closed |
|
|
11
Creative Planning
Overland Park,
Kansas
| – | -$2K | -5,000 | Closed |
|
AXN Hedge Fund Activity: Q3 2017 in Review
8 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q3 2017, worth a combined $53K — down 31% from $77K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AXN positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $37.8K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $36K sold.
- 8 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q3 2017, up from 7 in Q2 2017.
- Funds reported $53K of Aoxing Pharmaceutical Company Inc. stock for Q3 2017, down 31% quarter-over-quarter.
- 4 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q3 2017 and 3 closed out, a net change of +1 holder.
- The largest Aoxing Pharmaceutical Company Inc. buyer in Q3 2017 was Virtu Financial, an estimated $37.8K added.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q3 2017 was Renaissance Technologies, an estimated $36K sold.
Based on aggregated 13F filings for Q3 2017.